DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,082,000 | -44.5% | 152,900 | +2.7% | 0.00% | -33.3% |
Q2 2021 | $5,557,000 | +49.1% | 148,900 | +2.2% | 0.00% | +50.0% |
Q1 2021 | $3,726,000 | +18.2% | 145,700 | +1.8% | 0.00% | 0.0% |
Q4 2020 | $3,152,000 | +23.0% | 143,100 | +0.5% | 0.00% | 0.0% |
Q3 2020 | $2,562,000 | -27.9% | 142,400 | +1.8% | 0.00% | -33.3% |
Q2 2020 | $3,553,000 | +94.4% | 139,900 | +40.6% | 0.00% | +50.0% |
Q1 2020 | $1,828,000 | -15.4% | 99,500 | +1.4% | 0.00% | 0.0% |
Q4 2019 | $2,161,000 | +56.5% | 98,100 | +2.0% | 0.00% | +100.0% |
Q3 2019 | $1,381,000 | +0.1% | 96,200 | +9.8% | 0.00% | 0.0% |
Q2 2019 | $1,380,000 | +17.7% | 87,600 | +9.5% | 0.00% | 0.0% |
Q1 2019 | $1,172,000 | +45.2% | 80,000 | +6.0% | 0.00% | 0.0% |
Q4 2018 | $807,000 | -19.3% | 75,500 | +15.3% | 0.00% | 0.0% |
Q3 2018 | $1,000,000 | +50.8% | 65,500 | +21.1% | 0.00% | 0.0% |
Q2 2018 | $663,000 | – | 54,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |